Abstract

BackgroundIntestinal absorption of new quinolones is decreased by oral administration of polyvalent metal cations. Some clinical studies have demonstrated this drug - drug interaction is more prominent under fasted condition. However, the effect of food intake on the extent of drug - drug interaction between new quinolones and metal cations remains to be investigated quantitatively and systematically. The aim of this study was to develop an animal model that enables to evaluate the effect of food intake on the extent of drug - drug interaction in the gastrointestinal tract by chelation and to apply the model to evaluate quantitatively the effect of food intake on the drug - drug interaction between two new quinolones, ofloxacin or ciprofloxacin and sucralfate.MethodsThe rats were orally administered new quinolones (5.3 mg/kg of ofloxacin or 10 mg/kg of ciprofloxacin) with or without 13.3 mg/kg of sucralfate under fasted or fed condition and plasma concentration profiles of new quinolones were monitored. To the fed group, standard breakfast used in human studies was pasted and administered at a dose of 8.8 g/kg.ResultsThe area under the plasma concentration - time curves (AUC0–6) of ofloxacin and ciprofloxacin under the fasted condition were significantly decreased to 28.8 and 17.1% by co-administration of sucralfate, respectively. On the contrary, sucralfate moderately decreased the AUC0–6 of ofloxacin and ciprofloxacin to 54.9 and 33.2%, respectively, under fed condition. The effects of sucralfate and food intake on the kinetics of ofloxacin in this study were well consistent with the results of previous clinical trial.ConclusionsThe developed animal model quantitatively reproduced the effect of food intake on the drug - drug interaction between ofloxacin and sucralfate. The similar influences were observed for the drug - drug interaction between ciprofloxacin and sucralfate, suggesting that the extent of drug - drug interaction caused by chelation is generally attenuated by food intake.

Highlights

  • Intestinal absorption of new quinolones is decreased by oral administration of polyvalent metal cations

  • The aims of this study were 1) to develop an animal model using rats to evaluate the effect of food intake on the extent of drug-drug interaction (DDI) caused by chelation in the gastrointestinal tract, and in consequence to mimic the DDI between OFLX and AL observed in clinical trials, and 2) to quantitatively evaluate the effect of food intake, using the developed model, on the DDI between AL and ciprofloxacin (CPFX), another new quinolone antibiotics (NQs), in order to carefully evaluate the influence of food intake

  • Under the fed condition, the extent of decrease in the Cmax and AUC0–6 of the NQs by AL was smaller than the respective decrease under the fasted condition

Read more

Summary

Introduction

Intestinal absorption of new quinolones is decreased by oral administration of polyvalent metal cations. The aim of this study was to develop an animal model that enables to evaluate the effect of food intake on the extent of drug - drug interaction in the gastrointestinal tract by chelation and to apply the model to evaluate quantitatively the effect of food intake on the drug - drug interaction between two new quinolones, ofloxacin or ciprofloxacin and sucralfate. The aims of this study were 1) to develop an animal model using rats to evaluate the effect of food intake on the extent of DDI caused by chelation in the gastrointestinal tract, and in consequence to mimic the DDI between OFLX and AL observed in clinical trials, and 2) to quantitatively evaluate the effect of food intake, using the developed model, on the DDI between AL and ciprofloxacin (CPFX), another NQ, in order to carefully evaluate the influence of food intake.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call